Literature DB >> 9696016

Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand.

W Gong1, A Pecci, S Roth, B Lahme, M Beato, A M Gressner.   

Abstract

Cytokine-driven activation of hepatic stellate cells (HSC) in tissue injury and inflammation is a key pathogenetic event in liver fibrogenesis leading to an expanded pool of matrix producing myofibroblasts (MFB) which represent the transformed counterpart of HSC. We hypothesize that expansion of the pool of MFB might also be accomplished by modulation of apoptosis, which plays an opposite and complementary role to mitosis in the cellular homeostasis. We characterized the susceptibility of HSC in primary culture and of MFB in secondary culture to apoptosis induced by the soluble Fas ligand (sFasL) and related the effects to the expression levels of Fas (APO-1/CD95) and some major proapoptotic and contra-apoptotic protooncogenes. MFB showed a dose-dependent apoptotic reaction upon exposure to sFasL as evidenced by a strong increase of nucleosomal DNA fragments, loss of cellular DNA, positive TUNEL reaction, and annexin staining. The effect was found only if protein synthesis (cycloheximide) or RNA synthesis (actinomycin D) were arrested. HSC maintained for various times in primary culture were completely resistant to sFasL in combination with cycloheximide, but in late primary cultures (day 7 onward) an increasing susceptibility to sFasL-mediated apoptosis was developed. By semiquantitative reverse-transcriptase polymerase chain reaction (RT-PCR) analysis and alkaline phosphatase-anti-alkaline phosphatase staining Fas receptor was identified both in HSC and MFB at comparable expression levels. The expression of the contra-apoptotic protooncogenes bcl-2 and bcl-xl was found to be much stronger in early HSC than in late HSC and MFB as shown by ribonuclease protection assay. The expression of bcl-2 was additionally confirmed by semiquantitative RT-PCR and immunoblotting. Proapoptotic bax was found in comparable quantities at the RNA level in HSC and MFB but at the protein level MFB showed increased bax expression. It is concluded that transformation of HSC to MFB is paralleled by an increasing sensitivity to sFasL-mediated apoptosis, which might be related to a strong decrease of bcl-2 and bcl-xl expression, leading to a preponderance of proapoptotic gene expression in MFB. Modulation of apoptotic susceptibility of transforming HSC could be an important complementary pathway in the pathogenesis of fibrosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696016     DOI: 10.1002/hep.510280229

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

Review 1.  Is liver fibrosis reversible?

Authors:  R C Benyon; J P Iredale
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

2.  Salvia miltiorrhiza monomer IH764-3 induces hepatic stellate cell apoptosis via caspase-3 activation.

Authors:  Xiao-Lan Zhang; Li Liu; Hui-Qing Jiang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  Effects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE.

Authors:  Makoto Nakamuta; Kazuhiro Kotoh; Munechika Enjoji; Hajime Nawata
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

4.  Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors.

Authors:  R Issa; E Williams; N Trim; T Kendall; M J Arthur; J Reichen; R C Benyon; J P Iredale
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

5.  A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis.

Authors:  Richard G Ruddell; Fiona Oakley; Ziafat Hussain; Irene Yeung; Lesley J Bryan-Lluka; Grant A Ramm; Derek A Mann
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

Review 6.  Current research of hepatic cirrhosis in China.

Authors:  Xi-Xian Yao; Shu-Lin Jiang; Dong-Mei Yao
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

7.  The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression.

Authors:  Anping Chen; Li Zhang; Jianye Xu; Jun Tang
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

Review 8.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

9.  Absence of Nogo-B (reticulon 4B) facilitates hepatic stellate cell apoptosis and diminishes hepatic fibrosis in mice.

Authors:  Keitaro Tashiro; Ayano Satoh; Teruo Utsumi; Chuhan Chung; Yasuko Iwakiri
Journal:  Am J Pathol       Date:  2013-01-09       Impact factor: 4.307

10.  Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways.

Authors:  Joy X Jiang; Kenichiro Mikami; Senthil Venugopal; Yong Li; Natalie J Török
Journal:  J Hepatol       Date:  2009-05-03       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.